TS Financial Group (TSFG)’s GSK GSK Stock Holding History

TS Financial Group (TSFG)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Hold	254	–	–	﹤0.01%	571
2026 Q1	$14K	Hold	254	–	–	﹤0.01%	528
2025 Q4	$12K	Hold	254	–	–	﹤0.01%	545
2025 Q3	$11K	Hold	254	–	–	﹤0.01%	561
2025 Q2	$10K	Hold	254	–	–	﹤0.01%	551
2025 Q1	$10K	Hold	254	–	–	﹤0.01%	542
2024 Q4	$9K	Hold	254	–	–	﹤0.01%	503
2024 Q3	$10K	Hold	254	–	–	﹤0.01%	495
2024 Q2	$10K	Hold	254	–	–	﹤0.01%	484
2024 Q1	$11K	Hold	254	–	–	﹤0.01%	463
2023 Q4	$9K	Sell	254 -414	-62%	-$14.9K	﹤0.01%	526
2023 Q3	$24K	Hold	668	–	–	0.01%	391
2023 Q2	$24K	Sell	668 -200	-23%	-$7.17K	0.01%	391
2023 Q1	$31K	Hold	868	–	–	0.01%	343
2022 Q4	$31K	Sell	868 -40	-4%	-$1.33K	0.01%	338
2022 Q3	$27K	Sell	908 -1	-0.1%	-$38	0.01%	356
2022 Q2	$49K	Buy	909 +415	+84%	+$22.9K	0.02%	278
2022 Q1	$27K	Buy	494 +200	+68%	+$10.9K	0.01%	373
2021 Q4	$16K	Hold	294	–	–	0.01%	468
2021 Q3	$14K	Hold	294	–	–	0.01%	491
2021 Q2	$15K	Hold	294	–	–	0.01%	478
2021 Q1	$13K	Hold	294	–	–	0.01%	442
2020 Q4	$14K	Hold	294	–	–	0.01%	431
2020 Q3	$14K	Hold	294	–	–	0.01%	382
2020 Q2	$15K	Hold	294	–	–	0.01%	363
2020 Q1	$14K	Hold	294	–	–	0.01%	322
2019 Q4	$17K	Hold	294	–	–	0.01%	349
2019 Q3	$16K	Hold	294	–	–	0.01%	339
2019 Q2	$15K	Buy	294 +160	+119%	+$8.03K	0.01%	339
2019 Q1	$7K	Buy	+134	New	+$6.7K	0.01%	428

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TS Financial Group (TSFG)'s GSK Position: Q2 2026 in Review

TS Financial Group (TSFG) held its GSK (GSK) position steady in Q2 2026 at 254 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

TS Financial Group (TSFG) first reported a position in GSK in Q1 2019 and has held it in 30 quarters since. The position peaked at $49K in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

TS Financial Group (TSFG) held 254 shares of GSK worth $13K as of Q2 2026.
TS Financial Group (TSFG) left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #571 holding.
TS Financial Group (TSFG) first reported a position in GSK in Q1 2019 and has held it in 30 quarters since.
TS Financial Group (TSFG)'s GSK position peaked at $49K in Q2 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.